by Schmiegelow, K. et al.
The Institute of Gynecology, Obstetrics, and Pediatrics, The Faculty of Medicine, Denmark
The Institute of Gynecology, Obstetrics, and Pediatrics, The Faculty of Medicine, Denmark
These data suggest that children with ALL and TPMT wild type might have their cure rate improved, if the pharmacokinetics/-dynamics of TPMT low-activity patients could be mimicked without a concurrent excessive risk of second cancers.
Leukemia. 2009; 3:557-64